Secretion of growth factors from macrophages when cultured with microparticles

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 11, 2013, Pages 3170-3180

  Bhat, Archana ^a   Wooten, R Mark ^a   Jayasuriya, Ambalangodage Champa ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

bone morphogenetic protein; growth factors; macrophages; mesenchymal stem cells; osteoblasts; osteogenic markers

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEINS; GROWTH FACTOR; MESENCHYMAL STEM CELL; OSTEOGENIC; QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; QUANTITATIVE RT-PCR; TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; GENE EXPRESSION; OSTEOBLASTS; PHOSPHATASES; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

MACROPHAGES;

ALKALINE PHOSPHATASE; BETA ACTIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; CALCIUM PHOSPHATE; CHITOSAN; COLLAGEN TYPE 1; GROWTH FACTOR; LIPOPOLYSACCHARIDE; MEMBRANE ANTIGEN; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE CULTURE; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MORPHOGENETIC PROTEIN; GROWTH FACTORS; MACROPHAGES; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENIC MARKERS;

ANIMALS; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHITOSAN; COCULTURE TECHNIQUES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OSTEOBLASTS; PHENOTYPE;

EID: 84884909629     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34604     Document Type: Article

References (42)

1. Champagne CM, Takebe J, Offenbacher S, Cooper LF,. Macrophage cell lines produce osteoconductive signals that include bone morphogenic protein-2. Bone 2002; 30: 26-31.
2. Casstella MA,. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16: 21-26.
3. Cantini M, Carraro U,. Macrophage released factor stimulates selectively myogenic cells in primary muscle culture. J Neuropathol Exp Neurol 1995; 54: 121-128.
4. Lescaudron L, Peltekian E, Fontaine-Perus J, Paulin D,. Blood borne macrophages are essential for triggering muscle regeneration following muscle transplant. Neuromuscul Disord 1999; 3: 211-220.
5. Mosser DM, Edwards JP,. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
6. Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR,. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008; 181: 1232-1244.
7. Heinemann DE, Siggelkow H, Ponce LM, Viereck V, Wiese KG, Peters JH,. Alkaline phosphatase expression during monocyte differentiation. Overlapping markers as a link between monocytic cells, dendritic cells, osteoclasts and osteoblasts. Immunobiology 2000; 202: 68-81.
8. Baur ST, Mai JJ, Dymecki SM,. Combinatorial signaling through BMP receptor IB and GDF5: Shaping of distal mouse linmb and the genetics of distal limb diversity. Development 2000; 127: 605-619.
9. Engstrand T, Daluiski A, Melhus H, Lyons KM,. Transient production of bone morphogenic protein 2 by allagenic transplanted cells induces bone formation. Hum Gene Ther 2000; 11: 205-210.
10. Dean DB, Watson JT, Moed BR, Zhang Z,. Role of bone morphogenetic proteins and their antagonists in healing of bone fracture. Front Biosci 2009; 14: 2878-2888.
11. Tsiridis E, Upadhyay N, Giannoudis PV,. Molecular aspects of fracture healing: Which are the important molecules? Injury 2007; 38 (Suppl 1): S11.
12. Fujiwara N, Kobayashi K,. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 281-286.
13. Lazarus JJ, Kay MA, McCarter AL, Wooten RM,. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun 2008; 76: 1153-1162.
14. Dagtekin G, Schiffer R, Klein B, Jahnen-Dechent W,. Modulation of angiogenic functions in human macrophages by biomaterials. Biomaterials 2003; 24: 3395-3401.
15. Gordon S,. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
16. Pollard JW,. Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9: 259-270.
17. Harada Y, Wang JT, Doppalapudi VA, Willis AA, Jasty M, Harris WH, Nagase M, Goldring SR,. Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocyte/macrophages in vitro. J Biomed Mater Res 1996; 31: 19-26.
18. Bran G, Straeter J, Hormann K,. Apoptosis in bone for tissue engineering. Arch Med Res 2008; 39: 467-482.
19. Kato Y, Onishi H, Machida Y,. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 2003; 4: 303-309.
20. Portero A, Remuñañ-Lo pez C, Criado MT, Alonso MJ,. Reacetylated chitosan microspheres for controlled delivery of antimicrobial agents to the gastric mucosa. J Microencap 2002; 19: 797-809.
21. Di Martino A, Sittinger M, Risbud MV,. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005; 26: 5983-5990.
22. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M,. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005; 26: 3919-3928.
23. Zhao F, Yin Y, Lu WW,. Preparation and evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds. Biomaterials 2002; 23: 3227-3234.
24. Jayasuriya AC, Bhat A,. Mesenchymal stem cell function on hybrid organic/inorganic microparticles in vitro. J Tissue Eng Regen Med 2010; 4: 340-348.
25. Bhat A, Dreifke M, Gomez C, Kandimalla Y, Ebraheim NA, Jayasuriya AC,. Evaluation of cross-linked chitosan microparticles for bone regeneration. J Tissue Eng Regen Med 2010; 4: 532-542.
26. Greenwald SA, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN,. Bone-graft substitutes: Facts, fictions, and applications. J Bone Joint Surg Am 2001; 83: 98-103.
27. Jayasuriya AC, Bhat A,. Optimization of scaled-up chitosan microparticles for bone regeneration. Biomed Mater 2009; 4: 55006.
28. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG,. Bone marrow stromal cells: Characterization and clinical application. Crit Rev Oral Biol Med 1999; 10: 165-181.
29. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG,. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997; 63: 1059-1069.
30. Brown JP, Zachary JF, Teuscher C, Weis JJ, Wooten RM,. Dual role of interleukin-10 in murine Lyme disease: Regulation of arthritis severity and host defense. Infect Immun 1999; 67: 5142-5150.
31. Rama R, Sánchez J,. Transferrin uptake by bone marrow macrophages is independent of the degree of iron saturation. Br J Haematol 1992; 82: 455-459.
32. Gessl A, Boltz-Nitulescu G, Wiltschke C, Holzinger C, Nemet H, Pernerstorfer T, Förster O,. Expression of a binding structure for sialic acid-containing glycoconjugates on rat bone marrow-derived macrophages and its modulation by IFN, TNF-alpha, and dexamethasone. J Immunol 1989; 142: 4372-4377.
33. Dimitriou R, Tsiridis E, Giannoudis PV,. Current concepts of molecular aspects of bone healing. Injury 2005; 36: 1392.
34. Mountziaris PM, Mikos AG,. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 2008; 14: 179-186.
35. Huges FJ, Collyer J, Stanfield M, Godmann SA,. The effect of bone morphogenic protein 2, 4 and 6 on differentiation of rat osteoblast cell in vitro. Endocrinology 1995; 136: 2671-2677.
36. De Biase P, Capanna R,. Clinical applications of BMPs. Injury 2005; 36 (Suppl 3): S43-S46.
37. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJ,. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 2005; 87: 1367-1378.
38. Zhang Y, Zhang M,. Calcium phosphate/chitosan composite scaffold for controlled in vitro antibiotic drug release. J Biomed Mater Res 2002; 62: 378-386.
39. Lieberman JR, Daluiski A, Einhorn TA,. The role of growth factors in the repair of bone. Biology and clinical application. J Bone Joint Surg Am 2002; 84: 1032-1044.
40. Granjeiro JM, Oliveira RC, Bustos-Valenzuela JC, Sogayar MC, Taga R,. Bone morphogenetic proteins: From structure to clinical use. Braz J Med Biol Res 2005; 38: 1463-1473.
41. Ishaug-Riley SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG,. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997; 36: 17-28.
42. Jayasuriya AC, Bhat A,. Fabrication and characterization of novel hybrid organic/inorganic microparticles to apply in bone regeneration. J Biomed Mater Res A 2010; 92: 1280-1288.